Drugs / WC3055
last change Apr 2014 re-read 3 minutes ago

WC3055

Developed for
benign prostatic hyperplasia
Investigated by
Warner Chilcott

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01939184 Aug 2013 → Mar 2014 benign prostatic hyperplasia Warner Chilcott Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as WC3055 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01939184 ↗